Suppr超能文献

用于光动力癌症治疗的光敏剂开发的最新进展

Recent Advances in Developing Photosensitizers for Photodynamic Cancer Therapy.

作者信息

Chen Cong, Wang Jianmin, Li Xiaoyan, Liu Xiaolong, Han Xiao

机构信息

MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100176. China.

The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025. China.

出版信息

Comb Chem High Throughput Screen. 2017;20(5):414-422. doi: 10.2174/1386207320666170113123132.

Abstract

BACKGROUND & AIM: Photosensitizers are key molecules used in photodynamic cancer therapy (PDT), which is an effective therapeutic modality option for several diseases and nononcological disorders. Due to its lower systemic toxicity and its ability to destroy tumors selectively, PDT has been considered as clinical avenue for the treatment of several cancers.

METHODS & RESULTS: Three essential elements are involved in a PDT procedure: a photosensitizer, light of a specific wavelength, and singlet oxygen. However, the properties of conventional photosensitizers exhibit some drawbacks that may limit their use. Nanoparticles can provide significant benefits that counter these drawbacks and enable higher efficiency and biosafety. With the development of nanotechnology, nanoparticles have been used to encapsulate photosensitizers to enhance the phototoxic and pharmacokinetic properties of these agents.

CONCLUSION

Here, the main motivation for this review is to summarize recent progress in the development of photosensitizers, in particular, photosensitizers with nanoparticle modifications. In addition, we reviewed the clinical treatment of several diseases using photosensitizers formulated with nanoparticles, with the overall goal of aiding the design and development of novel photosensitizers.

摘要

背景与目的

光敏剂是光动力癌症治疗(PDT)中使用的关键分子,光动力癌症治疗是几种疾病和非肿瘤性疾病的一种有效治疗方式选择。由于其较低的全身毒性以及选择性破坏肿瘤的能力,光动力疗法已被视为治疗多种癌症的临床途径。

方法与结果

光动力疗法过程涉及三个基本要素:光敏剂、特定波长的光和单线态氧。然而,传统光敏剂的特性存在一些缺点,可能会限制它们的使用。纳米颗粒可以提供显著的优势来克服这些缺点,并实现更高的效率和生物安全性。随着纳米技术的发展,纳米颗粒已被用于包裹光敏剂,以增强这些药物的光毒性和药代动力学特性。

结论

在此,本综述的主要目的是总结光敏剂开发的最新进展,特别是纳米颗粒修饰的光敏剂。此外,我们回顾了使用纳米颗粒配制的光敏剂对几种疾病的临床治疗,总体目标是帮助新型光敏剂的设计和开发。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验